Robert J Bitterman - Net Worth and Insider Trading

Robert J Bitterman Net Worth

The estimated net worth of Robert J Bitterman is at least $12,742 dollars as of 2024-04-25. Robert J Bitterman is the President & CEO of Phio Pharmaceuticals Corp and owns about 18,990 shares of Phio Pharmaceuticals Corp (PHIO) stock worth over $12,742. Details can be seen in Robert J Bitterman's Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that Robert J Bitterman has not made any transactions after 2024-02-26 and currently still holds the listed stock(s).

Transaction Summary of Robert J Bitterman

To

Robert J Bitterman Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Robert J Bitterman owns 2 companies in total, including Phio Pharmaceuticals Corp (PHIO) , and Fibrocell Science Inc (FCSC) .

Click here to see the complete history of Robert J Bitterman’s form 4 insider trades.

Insider Ownership Summary of Robert J Bitterman

Ticker Comapny Transaction Date Type of Owner
PHIO Phio Pharmaceuticals Corp 2024-02-26 director
FCSC Fibrocell Science Inc 2004-12-31 director & President and CEO & Director

Robert J Bitterman Latest Holdings Summary

Robert J Bitterman currently owns a total of 1 stock. Robert J Bitterman owns 18,990 shares of Phio Pharmaceuticals Corp (PHIO) as of February 26, 2024, with a value of $12,742.

Latest Holdings of Robert J Bitterman

Ticker Comapny Latest Transaction Date Shares Owned Current Price ($) Current Value ($)
PHIO Phio Pharmaceuticals Corp 2024-02-26 18,990 0.67 12,742

Holding Weightings of Robert J Bitterman


Robert J Bitterman Form 4 Trading Tracker

According to the SEC Form 4 filings, Robert J Bitterman has made a total of 6 transactions in Phio Pharmaceuticals Corp (PHIO) over the past 5 years, including 6 buys and 0 sells. The most-recent trade in Phio Pharmaceuticals Corp is the acquisition of 2,500 shares on February 26, 2024, which cost Robert J Bitterman around $2,275.

Insider Trading History of Robert J Bitterman

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.
Total 0
  • 1
Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

Robert J Bitterman Trading Performance

GuruFocus tracks the stock performance after each of Robert J Bitterman's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Robert J Bitterman is 8%. GuruFocus also compares Robert J Bitterman's trading performance to market benchmark return within the same time period. The performance of stocks bought by Robert J Bitterman within 3 months outperforms 4 times out of 5 transactions in total compared to the return of S&P 500 within the same period.

You can select different timeframes to see how Robert J Bitterman's insider trading performs compared to the benchmark.

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Performance of Robert J Bitterman

Average Return

Outperforming Transactions

Each transaction is measured over a period and compared to .
1 Month 3 Months 6 Months 1 Year 2 Years 3 Years
Return(%) 11.51 8 -37.61 -80.13
Relative Return to S&P 500(%) 12 8.64 -45.26 -96.11

Robert J Bitterman Ownership Network

Ownership Network List of Robert J Bitterman

No Data

Ownership Network Relation of Robert J Bitterman


Robert J Bitterman Owned Company Details

What does Phio Pharmaceuticals Corp do?

Who are the key executives at Phio Pharmaceuticals Corp?

Robert J Bitterman is the director of Phio Pharmaceuticals Corp. Other key executives at Phio Pharmaceuticals Corp include Chief Development Officer Gerrit Dispersyn , Chief Development Officer John A Barrett , and director & President and CEO Geert Cauwenbergh .

Phio Pharmaceuticals Corp (PHIO) Insider Trades Summary

Over the past 18 months, Robert J Bitterman made 6 insider transaction in Phio Pharmaceuticals Corp (PHIO) with a net purchase of 13,215. Other recent insider transactions involving Phio Pharmaceuticals Corp (PHIO) include a net purchase of 9,000 shares made by Robert L Ferrara ,

In summary, during the past 3 months, insiders sold 0 shares of Phio Pharmaceuticals Corp (PHIO) in total and bought 2,500 shares, with a net purchase of 2,500 shares. During the past 18 months, 0 shares of Phio Pharmaceuticals Corp (PHIO) were sold and 7,810 shares were bought by its insiders, resulting in a net purchase of 7,810 shares.

Phio Pharmaceuticals Corp (PHIO)'s detailed insider trading history can be found in Insider Trading Tracker table.

To

Phio Pharmaceuticals Corp Insider Transactions

No Available Data

Robert J Bitterman Mailing Address

Above is the net worth, insider trading, and ownership report for Robert J Bitterman. You might contact Robert J Bitterman via mailing address: C/o Rxi Pharmaceuticals Corporation, 1500 West Park Drive, Suite 210, Westborough Ma 01581.

Discussions on Robert J Bitterman

No discussions yet.